CNSX:SNN

Smith & Nephew (SNN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
44,398 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SNN stock logo

About Smith & Nephew Stock (CNSX:SNN)

Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.

SNN Stock News Headlines

Gold Mania
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
Smith & Nephew PLC's Dividend Analysis
Smith & Nephew plans pay rise for US bosses
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?
Smith+Nephew To Buy Agili-C Developer CartiHeal In Up To $330 Mln Deal
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
18,581
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Anthony F. Holler M.D. (Age 71)
    Co-founder, CEO & Chairman
    Comp: $340.63k
  • Dr. Mark Hamish Kimmins (Age 56)
    Pres of NHS
    Comp: $4.68M
  • Mr. David Weinmann
    Global Controller & Interim CFO
  • Rob Knowles
    VP of Corp. Devel.
  • Mr. Jose Calderon
    Head of Grower

SNN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Canopy Growth (WEED), Energous (WATT), Cronos Group (CRON), Aurora Cannabis (ACB), CanniMed Therapeutics (CMED), CannTrust (CTST), CannaRoyalty (CNNRF) and Innovative Industrial Properties (IIPR).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:SNN) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners